These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1082 related articles for article (PubMed ID: 27127000)
1. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
2. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer. Xu Y; Wang C; Zhang Y; Jia L; Huang J Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer. Woopen H; Pietzner K; Richter R; Fotopoulou C; Joens T; Braicu EI; Mellstedt H; Mahner S; Lindhofer H; Darb-Esfahani S; Denkert C; Sehouli J J Gynecol Oncol; 2014 Jul; 25(3):221-8. PubMed ID: 25045435 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer. Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423 [TBL] [Abstract][Full Text] [Related]
7. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709 [TBL] [Abstract][Full Text] [Related]
8. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711 [TBL] [Abstract][Full Text] [Related]
9. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer. Meng Q; Duan P; Li L; Miao Y Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer. Lv Q; Sun H; Cao C; Gao B; Qi Y Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774 [TBL] [Abstract][Full Text] [Related]
12. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression. Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma. Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer. Ma Z; Wang X; He J; Xia J; Li Y PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer. Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978 [TBL] [Abstract][Full Text] [Related]
17. HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer. Wang Y; Li M; Meng F; Lou G Hum Pathol; 2017 Feb; 60():114-120. PubMed ID: 27818289 [TBL] [Abstract][Full Text] [Related]
18. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer. Li T; Xue H; Guo Y; Guo K Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cho H; Lee YS; Kim J; Chung JY; Kim JH Cancer Invest; 2013 Nov; 31(9):607-15. PubMed ID: 24164300 [TBL] [Abstract][Full Text] [Related]
20. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival. Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]